<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE302nnn/GSE302015/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302015</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Transcriptome signatures of SU-Eohyeol pharmacopuncture (SUEHP) in an MPTP-induced Parkinson's disease animal model</name><description>Parkinson’s disease (PD) is a progressive neurodegenerative disorder for which no definitive cure currently exists. The disease is primarily characterized by motor symptoms such as muscle rigidity, bradykinesia, and postural instability, along with a range of non-motor symptoms including pain, depression, sleep disturbances, and cognitive impairment. Given the absence of comprehensive therapeutic approaches that can effectively address both motor and non-motor manifestations of PD, we sought to investigate the potential therapeutic efficacy of SUEHP, a modality derived from traditional East Asian medicine. A mouse model of PD was established via administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), followed by SUEHP treatment administered twice weekly for a duration of two weeks. Based on compositional analysis of the pharmacopuncture formulation, cannabinoid receptor 1 (CB1) and peroxisome proliferator-activated receptor gamma (PPARγ) were identified as potential molecular targets. To assess their involvement, selective antagonists or inhibitors were co-administered. Transcriptomic analysis was subsequently conducted to characterize gene expression alterations associated with SUEHP treatment and to elucidate underlying mechanisms of action.</description><dates><publication>2026/06/10</publication></dates><accession>GSE302015</accession><cross_references><GSM>GSM9094220</GSM><GSM>GSM9094221</GSM><GSM>GSM9094222</GSM><GSM>GSM9094200</GSM><GSM>GSM9094212</GSM><GSM>GSM9094213</GSM><GSM>GSM9094214</GSM><GSM>GSM9094215</GSM><GSM>GSM9094216</GSM><GSM>GSM9094217</GSM><GSM>GSM9094218</GSM><GSM>GSM9094219</GSM><GSM>GSM9094191</GSM><GSM>GSM9094192</GSM><GSM>GSM9094193</GSM><GSM>GSM9094194</GSM><GSM>GSM9094195</GSM><GSM>GSM9094196</GSM><GSM>GSM9094230</GSM><GSM>GSM9094197</GSM><GSM>GSM9094198</GSM><GSM>GSM9094210</GSM><GSM>GSM9094199</GSM><GSM>GSM9094211</GSM><GSM>GSM9094201</GSM><GSM>GSM9094223</GSM><GSM>GSM9094224</GSM><GSM>GSM9094202</GSM><GSM>GSM9094225</GSM><GSM>GSM9094203</GSM><GSM>GSM9094204</GSM><GSM>GSM9094226</GSM><GSM>GSM9094227</GSM><GSM>GSM9094205</GSM><GSM>GSM9094228</GSM><GSM>GSM9094206</GSM><GSM>GSM9094207</GSM><GSM>GSM9094229</GSM><GSM>GSM9094208</GSM><GSM>GSM9094209</GSM><GPL>24247</GPL><GSE>302015</GSE><taxon>Mus musculus</taxon><PMID>[42218674]</PMID></cross_references></HashMap>